Hemodynamic effects of tolazoline. Studies in normal subjects and patients with mitral valvular disease, congenital heart disease and primary pulmonary hypertension.
D000293:Adolescent; D000328:Adult; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D005260:Female; D006330:Heart Defects, Congenital / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000503:physiopathology; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D014043:Tolazoline / Q000494:pharmacology*
D014043:Tolazoline; D010100:Oxygen